How Can AI Strengthen IP Rights for Biologics?

• Protecting biologics IP is increasingly difficult

• AI-driven biologic design offers potential solutions

• AI with experimental data enhances protection of closely related sequences

Speakers:

Christopher Negron

Principal Research Scientist II

AbbVie